We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Pfizer Inc | LSE:0Q1N | London | Ordinary Share | PFIZER ORD (CDI) |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
25.80 | 30.90 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 58.5B | 2.12B | 0.3753 | 76.15 | 159.51B |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
19:07:07 | O | 20 | 28.5388 | USD |
Date | Time | Source | Headline |
---|---|---|---|
03/10/2024 | 17:29 | ALNC | IN BRIEF: Haleon buys GBP230 million in shares from Pfizer |
01/10/2024 | 10:03 | ALNC | UPDATE: Pfizer cuts stake in Haleon to 15% with GBP2.7 billion sale |
30/9/2024 | 21:59 | ALNC | TOP NEWS: Pfizer to raise around GBP2.7 billion from Haleon stake sale |
25/9/2024 | 13:49 | ALNC | Pfizer, Moderna and BioNTech take patent fight to Court of Appeal |
16/9/2024 | 11:00 | ALNC | Pfizer hails positive results from two cancer treatment studies |
30/7/2024 | 12:35 | ALNC | TOP NEWS: Pfizer ups outlook amid first revenue hike since Covid boost |
01/5/2024 | 13:42 | ALNC | TOP NEWS: Pfizer profit declines on lower Covid-related sales |
23/4/2024 | 06:27 | ALNC | Moderna, Pfizer/BioNTech set for UK court clash over Covid jab patents |
09/4/2024 | 18:41 | ALNC | Pfizer RSV treatment meets targets in trial of adults under age 60 |
21/3/2024 | 16:29 | ALNC | TOP NEWS: Haleon buys back shares worth GBP315 million from Pfizer |
Pfizer (0Q1N) Share Charts1 Year Pfizer Chart |
|
1 Month Pfizer Chart |
Intraday Pfizer Chart |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions